Introduction to ARISE 2025

The ARISE 2025 Consensus Conference, taking place on May 29-30 in Washington, DC, will bring together over 50 independent clinical experts representing several professional societies, academic research organizations, the US Food and Drug Administration (FDA), and industry representatives.

  • These experts will discuss the scope of focused updates on new emerging technologies in the Neurovascular and non-vascular fields, and review and revise specific clinical endpoints.

  • The multidisciplinary process will result in important recommendations for clinical trial design, data reporting, preclinical research methods, endpoint definition and consenus formation to be published in a major neuroscience journal.

  • A writing committee consisting of independent experts will chair the expert workshops.

Through sessions on the Middle Meningeal Artery (MMA) as a pathway to new treatments, non-clinical requirements in neurointervention, and the role of AI and robotics, the ARISE 2025 Conference aims to deliver transformative guidelines and foster advancements in neurovascular care.

WHY ATTEND

The ARISE architecture encompasses 3 primary stakeholders involved in advancing research and practice for treating cerebrovascular disease: academia, comprising leading international physicians and scientists across relevant disciplines; industry, involving scientists and executives from private-sector pharmaceutical, device, and imaging companies; and regulatory institutions, consisting of executive managers, physicians, and scientists from esteemed organizations like the NIH and FDA.

LEARN MORE

ЕXPERT OPINIONS

SCIENTIFIC PROGRAM

INVITATION
ONLY

NETWORK

CORE ORGANIZERS

DISCOVER